Routine type 2 diabetes screening should start younger
This article was originally published in Clinica
It could be more cost-effective to screen all adults over 25 routinely for type 2 diabetes than to follow current US guidelines which target patients only over 45 years of age, US researchers have suggested.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.